4/A//SEC Filing
NEKTAR THERAPEUTICS 4/A
Accession 0001181431-07-058547
$NKTRCIK 0000906709operating
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 5:48 PM ET
Size
6.5 KB
Accession
0001181431-07-058547
Insider Transaction Report
Form 4/AAmended
HARKNESS TIMOTHY
SVP & Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2007-08-23$8.34/sh+200,000$1,668,000→ 200,000 totalExercise: $8.34Exp: 2015-08-23→ Common Stock (200,000 underlying)
Footnotes (3)
- [F1]The shares being reported were previously disclosed by the Reporting Person in a Form 3 filed on August 24, 2007. The Reporting Person is filing this Form 4 pursuant to Rule 16a 3(g)(1) of the Securities Exchange Act of 1934.
- [F2]25% of the shares subject to this employee stock option become exerciseable on August 23, 2008, and the remaining shares subejct to the stock option shall vest monthly thereafter so that all of the shares subject to the option shall be fully vested on August 23, 2011.
- [F3]This amended Form 4 is being filed to correct the number of derivative securities held by the Reporting Person following the transaction reported on this form.
Documents
Issuer
NEKTAR THERAPEUTICS
CIK 0000906709
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000906709
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 5:48 PM ET
- Size
- 6.5 KB